BioSpace News Archive

CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced that Brazil’s regulatory authority ANVISA has approved the previously submitted clinical trial protocol to commence patient enrollment in its CD17 trial for severe COVID-19 patients.

SpringWorks Therapeutics, Inc. announced that the Company will be evaluating mirdametinib, an investigational MEK inhibitor, in a platform study sponsored by Memorial Sloan Kettering Cancer Center and supported by SpringWorks exploring the compound both as a monotherapy and as a combination therapy in advanced solid tumors harboring MAPK-activating mutations.

Zimmer Biomet Holdings, Inc. reported financial results for the quarter ended June 30, 2021.

Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced participation in the following investor conferences in August

“We delivered strong performance this quarter, with volume-driven growth across our core business and most major geographies.

ObsEva SA announced that Company Management will provide a corporate update at the Wedbush PacGrow Healthcare Conference to be held August 10-11, 2021 and the Canaccord Genuity 41st Annual Growth Conference to be held August 10-12, 2021.

According to the report, the global lyophilized injectable market was valued over US$ 2.8 Bn in 2020 and is projected to expand at a CAGR of ~5% from 2021 to 2031.

According to the report, the global dengue vaccines market was valued at US$ 0.4 Bn in 2020 and is projected to expand at a CAGR of 11% from 2021 to 2031.

Novel technology, based on infrared spectroscopy, can accurately determine identity of pathogens and their susceptibility to antibiotics resistance in 30-40 minutes, directly from urine sample of patients

TRACON Pharmaceuticals announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the BTIG Virtual Biotechnology Conference on August 10, 2021 at 12:00pm Eastern Time.